Mark A. Sperling

9.8k citations
171 papers · 6.7k · 3 hit papers · h-index 38

Impact in

Papers in

    • Diabetes Management and Research 44
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 43
    • Growth Hormone and Insulin-like Growth Factors 23
    • Diabetes Treatment and Management 18
    • Pancreatic function and diabetes 45

Mark A. Sperling

162 papers receiving 6.3k citations

Mark A. Sperling's Hit Papers

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state 2018 · 473 citations
4730+16+32Years since publication100200300400

Peers

Mark A. Sperling
Comparison fields: 5 of 136
  • Endocrinology, Diabetes and Metabolism 3.0k
  • Obstetrics and Gynecology 469
  • Genetics 1.7k
  • Pediatrics, Perinatology and Child Health 949
  • Clinical Biochemistry 339
Replace R. D. G. Milner with:
R. D. G. Milner United Kingdom
A Aynsley‐Green United Kingdom
Héctor F. Escobar‐Morreale Spain
Marvin Cornblath United States
R K Kalkhoff United States
John Connell United Kingdom
Frederick C. Goetz United States
Ray E. Gleason United States
David J. Pettitt United States
Berthold Hocher Germany
Mark A. Sperling relative to R. D. G. Milner United Kingdom R. D. G. Milner's profile →
Citations per field
00.5×11.7×
R. D. G. Milner · 1×
Citations per year

Countries citing papers authored by Mark A. Sperling

Since Specialization
Citations

This map shows the geographic impact of Mark A. Sperling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Sperling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Sperling more than expected).

Fields of papers citing papers by Mark A. Sperling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Sperling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Sperling. The network helps show where Mark A. Sperling may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Sperling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Sperling Line = papers co-authored together Mark A. Sperling links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state
Hit paper breakdown →
2018473
2
Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children
Hit paper breakdown →
2015357
3 1997350
4
Measurement of “True” Glucose Production Rates in Infancy and Childhood with 6,6-Dideuteroglucose
Hit paper breakdown →
1977339
5 1987314
6 2014277
7 2006240
8 2009214
9 2004212
10 2009208
11 2010169
12 2015150
13 2007144
14 1990137
15 1981135
16 1990128
17 1984106
18 1980104
19 197799
20 198590

About Mark A. Sperling

Mark A. Sperling is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health, having authored 171 papers that have together received 6.7k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (45 papers), Diabetes Management and Research (44 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (43 papers), Diabetes and associated disorders (33 papers), Growth Hormone and Insulin-like Growth Factors (23 papers), Metabolism, Diabetes, and Cancer (21 papers), Birth, Development, and Health (18 papers) and Diabetes Treatment and Management (18 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.0k citations), Obstetrics and Gynecology (469 citations), Genetics (1.7k citations), Pediatrics, Perinatology and Child Health (949 citations) and Clinical Biochemistry (339 citations). Mark A. Sperling has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Ram K. Menon, Joseph I. Wolfsdorf, Nicole Glaser, Ragnar Hanås, Wayne S. Cutfield, C Bloch, Morey W. Haymond, Richard N. Bergman, Supriya Ganguli and Dennis M. Bier. Their work appears in journals such as The Journal of Pediatrics, Pediatric Research, American Journal of Physiology-Endocrinology and Metabolism, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact